Resveratrol and gum health: what the polyphenol research actually shows
Resveratrol gets pitched as a wonder polyphenol for everything from heart health to longevity, but its track record for gums is messier than the supplement aisle suggests. Here is the laboratory work, the human trials, and where the marketing runs ahead of the evidence.
Resveratrol is a plant polyphenol best known from red grape skins and Japanese knotweed. Laboratory and animal studies show it can reduce gum inflammation by activating SIRT1, slow alveolar bone loss, and disrupt biofilms from Porphyromonas gingivalis. Human trials are small, short, and almost all use it as an add-on to scaling and root planing performed by a dentist. The honest read: real biological signal, real promise as an adjunct, but no replacement for daily plaque control, fluoride or nano-hydroxyapatite for enamel, or a professional cleaning.
Right fit: people with chronic mild gingivitis who want to layer in evidence-based dietary polyphenols. Wrong fit: anyone hoping a supplement will reverse advanced periodontitis or replace brushing and interdental cleaning.
- Key terms glossary
- What exactly is resveratrol, and why are dentists studying it?
- How does resveratrol affect inflammation in gum tissue?
- Can resveratrol actually fight the bacteria behind gum disease?
- What do the human clinical trials actually show?
- How does resveratrol compare to other oral-health polyphenols?
- Does resveratrol do anything for tooth enamel?
- Should you take a resveratrol supplement for gum health?
- Where do polyphenols fit into a remineralization-first routine?
- FAQ
Key terms you will see in this guide
A stilbenoid polyphenol (chemical formula C14H12O3) produced by certain plants under stress. The main commercial source is Japanese knotweed root; dietary sources include red grape skins, blueberries, peanuts, and mulberries.
A broad class of plant compounds containing multiple phenolic hydroxyl groups. Polyphenols include flavonoids, stilbenes, lignans, and tannins. They are studied for antioxidant and anti-inflammatory activity in many tissues, including gums.
A chronic inflammatory disease of the tissues that support the teeth (gum, periodontal ligament, alveolar bone). It is driven by dysbiotic bacterial biofilm and a sustained host inflammatory response, and can lead to attachment loss and tooth mobility.
A NAD+-dependent deacetylase enzyme involved in stress response, metabolism, and inflammation control. Resveratrol is a SIRT1 activator and most of its anti-inflammatory effects in gum tissue trace back to this pathway.
A Gram-negative anaerobic bacterium considered a keystone pathogen in chronic periodontitis. It manipulates host immunity, requires iron (hemin) for growth, and is the most studied microbial target for polyphenol interventions in periodontal research.
The portion of the jawbone that contains the tooth sockets. Loss of alveolar bone is the structural consequence of advancing periodontitis and is what makes the condition irreversible at later stages.
A treatment given alongside the main therapy to improve outcomes. In periodontology, the main therapy is mechanical biofilm removal (scaling and root planing). An adjunct does not replace the mechanical step.
What exactly is resveratrol, and why are dentists studying it?
Resveratrol is a stilbenoid polyphenol that plants make when they are stressed by fungi, ultraviolet light, or injury. The big dietary sources are red and purple grape skins, blueberries, mulberries, peanuts (in small amounts), and Japanese knotweed root, which is what almost every commercial supplement on the shelf is extracted from. It was first isolated in 1939 by Japanese chemist Michio Takaoka from white hellebore, then sat in obscurity until the 1990s, when the French paradox put red wine and resveratrol in the same conversation about cardiovascular health.
For oral health specifically, the interest is more recent. The first wave of dental research traces back to the mid-2000s, when broader polyphenol reviews started flagging consistent anti-inflammatory effects in gum tissue models. By 2013, a paper in the Journal of Periodontal Research showed that human gingival fibroblasts (the connective tissue cells in your gums) responded to resveratrol exposure with downregulated production of pro-inflammatory cytokines, the chemical messengers that drive the redness, swelling, and bleeding that people call gingivitis.
Researchers stayed interested for three reasons. First, resveratrol activates SIRT1, a sirtuin enzyme that sits at the center of cellular stress and inflammation control. SIRT1 activation pushes back against the NF-kappa-B pathway, which is the master switch for chronic gum inflammation. Second, in cell culture, resveratrol disrupts biofilm formation by Porphyromonas gingivalis, the keystone bacterium in chronic periodontitis. Third, in rodent models of ligature-induced periodontitis, oral resveratrol slows the rate of alveolar bone loss around the affected teeth.
The bioavailability problem nobody likes to talk about
Each of those mechanisms is real. None of them automatically translates to a clinical effect you can feel by chewing more grapes or taking a 250 milligram capsule from a supplement aisle. The translation problem comes down to one inconvenient fact about resveratrol pharmacokinetics: when you swallow it, the body absorbs it well, but the liver conjugates and excretes it so quickly that less than one percent of the dose ever reaches the bloodstream in its free, biologically active form. That number has stayed consistent across two decades of human pharmacokinetic literature, including reviews summarised by the Journal of Dentistry and oncology pharmacology groups.
For dentistry, that pharmacokinetic limitation cuts two ways. It explains why some high-dose oral supplement trials look underwhelming. It also opens an obvious workaround: deliver the compound where it needs to act. Topical or chewable formulations let the polyphenol contact gum tissue and biofilm directly, without depending on plasma concentrations that the gut and liver will not allow. That is the angle the more recent research has leaned into, with resveratrol-containing mouthwashes, gels, and lozenges showing up in the literature, and the adjunctive-therapy trials we will get to below mostly handing a 480 milligram capsule to a patient under dentist supervision rather than expecting diet alone to do the work.
The compound has real anti-inflammatory and mild antibacterial properties measured in laboratories. The dose required to get those effects in your gums is far higher than what any reasonable diet delivers. And the delivery route that matters for gum health is topical, not systemic. A dentist using resveratrol as an adjunct after a deep clean is doing something the evidence at least loosely supports. A wine glass after dinner is doing something pleasant for you, but the resveratrol in it is a footnote to the experience, not a periodontal therapy.
How does resveratrol affect inflammation in gum tissue?
If you only remember one thing about how resveratrol acts on gums, make it this: it is primarily an anti-inflammatory compound, not an antibacterial one. The antibacterial activity exists, but the cytokine-quieting effect on host tissue is where the literature is most consistent.
Mechanism 1: SIRT1 activation
SIRT1 is a NAD+-dependent deacetylase enzyme that regulates a long list of inflammatory pathways. When SIRT1 is active, it deacetylates the p65 subunit of NF-kappa-B and tones down the transcription of inflammatory cytokines like IL-6, IL-8, and TNF-alpha. In chronic gingivitis and periodontitis, those cytokines are the chemical messengers that drive the redness, bleeding, and gum recession people experience day to day.
A 2014 study published in the Journal of Periodontal Research showed that human gingival fibroblasts treated with resveratrol significantly downregulated IL-6 and IL-8 production after LPS challenge (LPS is the bacterial endotoxin that triggers the inflammatory cascade in gum tissue). The effect was dose-dependent, and it could be blocked by SIRT1 inhibitors, which strongly suggests SIRT1 is the actual mediator rather than a non-specific antioxidant effect.
Mechanism 2: MMP inhibition
Matrix metalloproteinases (MMPs), especially MMP-8 and MMP-9, are the enzymes that break down the collagen scaffolding of gum tissue and periodontal ligament during active periodontitis. They are why the disease is destructive, not just inflammatory. In vitro work has shown resveratrol can inhibit MMP-9 expression in stimulated gingival cells, and an animal model published in Clinical Oral Investigations documented reduced alveolar bone loss in ligature-induced periodontitis rats treated systemically with resveratrol.
Mechanism 3: Oxidative stress reduction
Gingivitis and periodontitis involve sustained production of reactive oxygen species (ROS) in inflamed tissue. ROS damage cell membranes, oxidise lipids, and amplify the inflammatory response. Polyphenols broadly are direct radical scavengers. A 2018 review of dietary polyphenols in BDJ Open noted that resveratrol reduces malondialdehyde (a marker of lipid peroxidation) in gum tissue of diabetic rats, and improves the redox balance in saliva samples from patients with chronic periodontitis.
Three caveats apply to all three mechanisms. Most of the mechanistic work is in vitro (cell culture), where doses can be set arbitrarily. The doses required to see the cytokine and MMP effects are higher than what dietary intake delivers and often higher than what systemic supplementation achieves in target tissue. And the distinction between topical contact and systemic exposure matters enormously, because resveratrol that never reaches your gum tissue in adequate concentration cannot do any of this.
Can resveratrol actually fight the bacteria behind gum disease?
Periodontal disease is a host response to a dysbiotic biofilm. The bacterial side of the story revolves around the so-called red complex: Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. These are anaerobic species that thrive in the deep periodontal pocket and orchestrate much of the tissue destruction. If a compound can disrupt their biofilm or starve their growth, it has a credible mechanistic case as a periodontal adjunct.
In vitro, resveratrol does both. A frequently cited paper in Caries Research adjacent oral microbiology literature reported that resveratrol concentrations of 50 to 200 micrograms per millilitre disrupted P. gingivalis biofilm formation, with measurable inhibition of fimbrial expression and adhesion to oral epithelial cells. Subsequent work identified three plausible mechanisms: interference with hemin (iron) uptake (P. gingivalis is hemin-dependent for growth), disruption of quorum sensing through autoinducer signalling, and direct membrane disturbance at higher concentrations.
For Streptococcus mutans, the main cariogenic species, resveratrol shows weaker but still measurable activity. It reduces lactic acid production and slows the formation of glucan-rich biofilm matrix at higher concentrations. The effect size is far smaller than what xylitol achieves on the same organism. The American Dental Association still treats xylitol as the more reliable dietary intervention for S. mutans suppression, supported by trials showing up to 75 percent reductions in salivary S. mutans counts with consistent use.
The concentrations that work in vitro are 10 to 100 times higher than what dietary intake provides. A glass of red wine delivers roughly 0.2 to 2 milligrams of resveratrol. Achieving the 50 to 200 microgram per millilitre concentration that inhibits P. gingivalis in a petri dish would require either a topical delivery vehicle or an oral dose well above what supplements typically contain. The clinical relevance, then, is for targeted formulations contacting gum tissue directly, not for adding red grapes to a fruit bowl.
What do the human clinical trials actually show?
This is where the picture gets interesting and a little frustrating. The strongest human signal for resveratrol in periodontology comes from adjunctive trials, where the supplement is paired with scaling and root planing (SRP), the mechanical biofilm-removal procedure that is the foundation of any non-surgical periodontal treatment.
A 2017 randomised controlled trial published in Clinical Oral Investigations (Javid and colleagues) enrolled diabetic patients with chronic periodontitis and randomised them to 480 milligrams of resveratrol per day or placebo for four weeks, on top of SRP. The resveratrol arm showed significantly greater reductions in probing pocket depth and clinical attachment level than the placebo arm, plus reductions in systemic markers of inflammation that were arguably driven by the patients' diabetic status as much as their periodontal status.
A parallel 2017 trial reported in the Journal of Periodontology used a similar adjunctive design and found reduced IL-6 in gingival crevicular fluid at the eight-week mark. The effect size in both trials was modest in absolute terms (sub-millimetre changes in pocket depth) but consistent enough that the adjunctive case is no longer purely speculative.
The limitations of the existing trials
The picture is not as clean as the supplement marketing suggests. Five specific limitations apply:
1. Sample sizes are small. Most of the published trials enrol 40 to 60 patients, which is enough to detect large effects but not enough to confidently rule out moderate ones.
2. Trial durations are short. Four to twelve weeks is enough to capture acute inflammatory changes but not enough to evaluate whether the benefit persists, plateaus, or fades. Periodontitis is a chronic disease, and short-term improvements after SRP frequently rebound without long-term maintenance.
3. There are no resveratrol-alone trials. Every credible RCT has tested resveratrol as an add-on to SRP, never as a standalone therapy. Reading the literature carefully, the case is for adjunctive use under dentist supervision, not for self-prescribing.
4. Doses are heterogeneous. The cited trials use anywhere from 250 to 1000 milligrams per day, sometimes once daily, sometimes split. The dose response is not well characterised.
5. Most trials are in metabolically compromised populations, especially patients with type 2 diabetes. That is a group where periodontitis and systemic inflammation are tightly coupled, which can magnify the apparent effect of an anti-inflammatory intervention. Whether the same effect size would appear in otherwise healthy patients with localised gingivitis is unknown.
A systematic review on resveratrol for periodontitis has not yet been issued by the Cochrane Library, which is the usual gold standard for confirming that an intervention has crossed the threshold from promising to recommendable. The polyphenol field broadly acknowledges that the honest summary is still "more high-quality trials are needed," not "validated adjunctive therapy."
How does resveratrol compare to other oral-health polyphenols?
Resveratrol is not the only polyphenol with oral-health credentials. Several others have larger or older evidence bases. Lining them up side by side helps clarify which compounds are worth taking seriously and which are mostly riding on supplement-industry momentum.
A few patterns jump out of the table. No single polyphenol dominates across every category. The traditional remedies (mastic, green tea) often have more consistent human data than the supplement-marketed compounds (resveratrol, curcumin), partly because they have a longer head start and partly because their delivery formats place the polyphenol directly in the mouth rather than asking it to survive first-pass liver metabolism.
Of these, mastic stands out for one specific reason: it has documented antibacterial activity against P. gingivalis at concentrations achievable through chewing, not just at supplement-level doses. That makes it interesting for daily-use formats in a way that resveratrol, with its capsule-only clinical track record, is not. Green tea catechins occupy a similar practical niche if you happen to enjoy drinking several cups a day.
Does resveratrol do anything for tooth enamel?
Mostly no, with one interesting twist. Tooth enamel is roughly 97 percent hydroxyapatite by weight, with a Mohs hardness of 5 and a critical demineralisation threshold at pH 5.5. Remineralising damaged enamel requires calcium and phosphate ions plus a delivery mechanism: saliva, fluoride, nano-hydroxyapatite, or casein phosphopeptide-amorphous calcium phosphate (CPP-ACP). Polyphenols do not supply those minerals, and they do not act on the hydroxyapatite lattice directly.
A 2022 systematic review in Clinical Oral Investigations concluded that nano-hydroxyapatite shows comparable remineralisation potential to fluoride in laboratory conditions, and the European Scientific Committee on Consumer Safety (SCCS) confirmed nano-hydroxyapatite's safety profile for oral-care use in 2023. Resveratrol is simply not in the same conversation for enamel.
The pellicle angle (the interesting twist)
Polyphenols can affect the demineralisation side of the equation. The acquired enamel pellicle is the thin proteinaceous film that coats your teeth between cleanings; it is the first line of defence against acid attack. A 2019 paper in the Journal of Dentistry showed that polyphenol-rich tea extracts can integrate into the pellicle, modifying its protein composition and slightly reducing acid penetration during a citric-acid challenge. Similar effects have been reported for grape-derived polyphenols, including small contributions from resveratrol.
The effect size is small, and it is also the source of the visible staining that comes with heavy tea, coffee, and red wine consumption. Functionally, the pellicle modification is real but not a substitute for active remineralisation. For enamel specifically, the evidence-based actors remain fluoride, nano-hydroxyapatite, calcium phosphate, and the saliva your own glands produce. Resveratrol's lane is gum tissue, not enamel, and any marketing that implies otherwise is overreaching.
Should you take a resveratrol supplement for gum health?
The honest answer is probably not as your first move. The supplement aisle is full of products that look biologically plausible until you compare their evidence-per-euro to what a basic oral-care routine actually achieves. Resveratrol fits that pattern.
A five-step priority ladder for gum health
1. Daily plaque control. Brushing twice a day for two minutes with a soft-bristled brush, plus interdental cleaning (floss, interdental brushes, or water flosser) every day. This is non-negotiable and remains the single highest-leverage intervention. The American Dental Association consistently puts mechanical biofilm removal at the top of every gum-health guideline.
2. Reduce sugar frequency, not just total amount. Cariogenic bacteria respond to how often they get fed more than to how much. Cutting snacking frequency does more for the bacterial side of gum and tooth health than cutting calories.
3. Add a remineralisation agent for enamel. Either fluoride toothpaste at 1000-1450 parts per million, or a nano-hydroxyapatite product, or both depending on caries risk. This is enamel-focused, not gum-focused, but it lives in the same daily routine.
4. Address dry mouth if it applies. Reduced salivary flow is one of the most underappreciated drivers of both gum disease and cavities. Causes range from medications to mouth-breathing to dehydration. Xylitol-based gums, frequent water sips, and humidifiers all help.
5. Quit smoking. Tobacco use is the single largest modifiable risk factor for periodontitis, and the effect size dwarfs anything any supplement has demonstrated in any trial.
Adjunctive use, supervised. If you are being treated for chronic periodontitis under a dentist's care and would like to layer in evidence-based dietary polyphenols, resveratrol has at least a plausible case as an add-on to SRP. Talk to your dentist about it; do not treat it as a standalone fix. Doses in the cited trials are 250-1000 mg/day; the most-cited adjunctive design uses 480 mg/day for four weeks.
Resveratrol can interact with blood thinners (warfarin, DOACs), NSAIDs (additive bleeding risk), and drugs metabolised by the CYP3A4 enzyme. People with bleeding disorders, those preparing for surgery, and people taking prescription medication should clear supplementation with their doctor first. Doses above 1 gram per day can cause gastrointestinal side effects; the trials supporting periodontal benefit use far lower doses than that ceiling.
Where do polyphenols fit into a remineralization-first routine?
Gum health and enamel health are different problems with different evidence-based solutions, but they share daily-routine real estate. The trap is treating them as one problem and assuming any polyphenol pitched at oral health does the job of both. It does not.
A remineralisation-first stack starts with the enamel side, because enamel damage is harder to reverse than gum inflammation. Nano-hydroxyapatite or fluoride does the heavy lifting on the mineral structure (a 2022 review in Clinical Oral Investigations showed comparable remineralisation potential between the two under laboratory conditions). Xylitol suppresses cariogenic bacteria. Saliva-stimulating habits (chewing, sips of water, avoiding mouth-breathing) buffer acid attacks.
Polyphenols enter the picture for two reasons. They add an anti-inflammatory and antibacterial layer specifically focused on gum tissue, which the remineralisation agents do not touch. And several of them double as natural flavour-and-resin components in chewable formats, where they get topical contact with the gum line that supplements cannot achieve.
Why Minvelle is not a resveratrol product
Minvelle is a remineralising chewing gum. The active stack is nano-hydroxyapatite (for enamel), xylitol and erythritol (for cariogenic bacteria suppression and saliva stimulation), and a layered set of plant resins: Chios mastic, myrrh, spruce, and acacia gum. Spearmint oil and a small terpene blend round out the sensory profile. The gum base itself is chicle, the traditional non-synthetic alternative.
We did not add resveratrol for two reasons. First, the human evidence for resveratrol in a chewing-gum delivery format is not there. The trials that support periodontal benefit use capsules under dentist supervision at 250-1000 mg per day. Reproducing that exposure in a chewing format would require either an impractical dose per piece or a clear bioavailability story that nobody has published. Second, the polyphenol-rich plant resins already in the recipe (especially mastic) cover a similar mechanistic angle (anti-Porphyromonas activity, anti-inflammatory effect) with a much longer human track record. Chios mastic has been used as a chewing resin for oral health for more than 2,000 years in the eastern Mediterranean, and modern in vitro work, summarised in reviews including those indexed by the BDJ Open ecosystem, supports its activity against P. gingivalis.
The point is not that polyphenols do not work, it is that the ones with real oral-cavity evidence in real delivery formats deserve the spotlight, and the ones whose evidence lives in capsule trials should stay in capsule trials until someone runs the human work on the chewable format. The honest story sells less than a buzzword on the front of a package, but it is the story that holds up when you read the actual papers.
The cheapest, highest-evidence approach is dietary: green tea (two to three cups a day for catechin intake), berries and grapes with the skins on, dark chocolate (70% or higher), extra-virgin olive oil, herbs and spices. For oral-cavity-specific polyphenols, mastic-containing chewing gums and green-tea mouth rinses have the strongest delivery-format case. Consider learning more about the basics of remineralising teeth naturally if you are building a routine from scratch.
Who is a good fit for a polyphenol-rich oral-care routine?
If your hygienist keeps flagging mild bleeding on probing, and you already brush and floss daily, a dietary polyphenol layer (green tea, berries, mastic gum) is a low-risk addition with at least mechanistic and modest human-trial support. It will not replace plaque control, but it can compound the effect.
Chewing in itself raises saliva flow, which is good for both enamel and gum health. A gum that combines xylitol (for bacteria), nano-hydroxyapatite (for enamel), and polyphenol-rich resins (for gum tissue) covers more ground in one daily habit than a pure resveratrol capsule could.
This is the one case where a resveratrol capsule has a defensible evidence base, but only as an add-on to SRP and only under professional supervision. Bring the published trials to the conversation, not the supplement bottle.
Who should not lean on resveratrol for gum health?
No polyphenol, no supplement, and no chewing product compensates for not removing biofilm mechanically. The evidence for plaque control is decades stronger than the evidence for any polyphenol adjunct.
Resveratrol supplements can magnify bleeding risk and affect liver enzyme activity. If you are on warfarin, a direct oral anticoagulant, regular NSAIDs, or a CYP3A4-metabolised drug, talk to your doctor before adding a polyphenol supplement at trial doses.
Advanced periodontitis with deep pocketing and bone loss requires professional intervention. The published adjunctive trials show sub-millimetre changes in pocket depth, which is meaningful at the population level but not a rescue therapy for severe disease.
This article is informational. It is not medical advice. Talk to your dentist before changing your oral-care routine, especially if you have active caries, sensitivity beyond mild, or systemic conditions affecting oral health. Claims relating to resveratrol, nano-hydroxyapatite, xylitol, and mastic resin are based on ingredient-level research, not on clinical trials of the Minvelle finished product.
Reads dental research daily. Not a medical professional. Every Minvelle post is fact-checked against primary sources, and no LLM-generated content goes live unedited. Read the full story here.
Frequently asked questions
Does drinking red wine improve gum health?
A glass of red wine delivers roughly 0.2 to 2 milligrams of resveratrol, which is far below the doses used in the dental clinical trials (250 to 1000 milligrams per day). Red wine is also acidic with a pH around 3.5, so the net effect on oral tissue is more likely to be enamel erosion than gum protection. If you enjoy wine, drink it. Do not treat it as a periodontal therapy.
Is resveratrol safe to take daily?
Doses up to about 1 gram per day appear well tolerated in healthy adults in short-term human studies. Common side effects at higher doses include mild gastrointestinal upset. Resveratrol can interact with blood thinners, NSAIDs, and drugs metabolised by the CYP3A4 enzyme. If you take prescription medication or have a bleeding disorder, talk to your doctor before starting a supplement.
How does resveratrol compare to fluoride or nano-hydroxyapatite for teeth?
They are not in the same category. Fluoride and nano-hydroxyapatite are remineralization agents that act on tooth enamel, which is roughly 97 percent hydroxyapatite by weight. Resveratrol is a polyphenol that acts on gum tissue and oral bacteria, not on the mineral structure of enamel. The two address different problems and the evidence base for fluoride and nano-hydroxyapatite on enamel is far larger than anything published on resveratrol for teeth.
Can resveratrol reverse periodontitis?
No supplement can reverse periodontitis on its own. The current human trials use resveratrol as an adjunct to scaling and root planing performed by a dental professional, not as a standalone treatment. In those adjunctive studies it produces small but measurable improvements in pocket depth and inflammatory markers, particularly in patients with diabetes. Mechanical plaque removal remains the foundation of any periodontal therapy.
Are there resveratrol mouthwashes or chewing gums on the market?
A small number of resveratrol-containing mouthwashes and gels exist mostly in research settings, and a handful have reached niche consumer products. There is no validated, mass-market resveratrol chewing gum with peer-reviewed efficacy data behind it. The delivery format is theoretically attractive because it places the polyphenol in direct contact with gum tissue, but the human data needed to make confident claims has not yet been published.
What dose of resveratrol is used in dental studies?
The most cited adjunctive periodontitis trials use 480 milligrams per day in two divided doses over four to twelve weeks. Some trials go up to 1000 milligrams per day. These doses are roughly 100 to 1000 times higher than what a normal diet delivers from grapes, berries, and peanuts. That gap explains why dietary intake alone is unlikely to produce the effects seen in the supplement-dose trials.
Does Minvelle contain resveratrol?
No. Minvelle gum is built on nano-hydroxyapatite for enamel remineralization, xylitol to reduce cariogenic bacteria, and a stack of polyphenol-rich plant resins (Chios mastic, myrrh, spruce) with documented antibacterial and anti-inflammatory activity. We did not include resveratrol because the human evidence for a chewing-gum delivery format is not there yet, and we would rather not market a compound whose oral-cavity dose response in a gum format is still untested.
- Journal of Periodontal Research, resveratrol downregulates IL-6 and IL-8 in LPS-stimulated human gingival fibroblasts, 2014.
- Clinical Oral Investigations, Javid et al., resveratrol as adjunct to scaling and root planing in diabetic chronic periodontitis, 2017, and 2022 systematic review on nano-hydroxyapatite remineralisation potential.
- Journal of Periodontology, reduced gingival crevicular fluid IL-6 with adjunctive resveratrol, 2017.
- BDJ Open, dietary polyphenols and periodontal inflammation review, 2018.
- Journal of Dentistry, polyphenol-rich tea extracts and acquired enamel pellicle, 2019.
- Caries Research, polyphenol activity against oral biofilm pathogens, adjacent oral microbiology literature.
- European Scientific Committee on Consumer Safety, opinion on hydroxyapatite (nano) in oral hygiene products, 2023.
- American Dental Association, evidence-based clinical guidelines on plaque control and adjunctive therapies in periodontology.
- Cochrane Library, systematic reviews on adjunctive non-surgical periodontal therapies.
Build the routine the research actually supports
Nano-hydroxyapatite for enamel. Xylitol for bacteria. Polyphenol-rich plant resins (Chios mastic, myrrh, spruce) for gums. Use code ENAMEL10 at checkout. 30-day money-back guarantee. No commitment on the first order.
Try Minvelle →